Hello all,
We had a teleconference today to discuss the feedback that we got from 
Nature. The next call will be in one week, *Thursday 31st at 4pm CET. *
*A**ction item*s:
     - Everyone: by next week's call, please think/discuss within your 
group what kind of future companion projects you are working or are 
planning to launch based on Geuvadis data/samples.
     - all who have added content to the wiki: please go through the 
material that you have there: delete outdated content, and if needed: 
add material and reorganize. Some missing content is tolerable, 
incorrect information is not.
A brief summary of today's discussion:
- Manolis and myself have sent Nature's editor Magdalena Skipper a 
rebuttal letter to address the points raised by the reviewers, and the 
plan is to discuss with her soon. Let's hope that she will give us the 
chance to revise the paper after all - we think that there's a decent 
chance.
- On the call there was discussion of some of the most important 
questions that the reviewers raised and the potential improvements based 
on that (regardless of whether we'll resubmit to Nature or to another 
journal). Depending on what happens with Nature, I'll coordinate the 
details of the revisions later with the respective people.
     - Figure 1c raised questions but it's a pretty strong analysis 
already. Include the splicing manuscript in the next submission will 
show that we've worked on these questions in further depth
     - data access: from the Geuvadis browser we'll provide downloads of 
the full master files as well as regions. The Ensembl broswer where the 
bams can be visualized doesn't have a slicing functionality and it's 
well beyond our resources to start building that. Tuuli will provide 
Natalja with a list of the final master files of quantifications etc. 
that we'll want to share once the paper is out.
     - Jean is doing some additional analysis to estimate how robust the 
transcript variation statistics are to lowly expressed gene as well as 
lowly expressed transcripts of highly expressed genes.
     - In addition to transcript ratio QTLs, we could also do 
polyadenylation QTLs - Pedro has quantified these already, and it might 
add to the novelty of the paper and address the question of variation in 
transcript structure.
     - Regarding the robustness of the analysis, Peter had a good idea 
of taking the old eQTLs from April (different mapper, normalization and 
eQTL method, analysis by population) to show that the results are highly 
overlapping (I believe and hope that they are). We could also e.g. 
quantify 5 samples with Cufflinks and show that flux is similar but 
better, or map to personalized genomes, but we need to think very 
carefully how deep we want to get into these types of analyses and how 
we'd interpret the results before we do anything. Regarding allelic 
mapping bias, it should be enough if we just describe Tuuli's existing 
analysis better in the paper.
     - One of the reviewers suggested that dropping some of the analyses 
might improve the paper. I'm not keen to do that, but we'll discuss this 
with Magdalena and if she wants us to do that, that's what we'll do.
     - Gabrielle created a visitor read-only access to the wiki so that 
the reviewers can go and take a look.
So, now it's time to cross your fingers again and hope that our letter 
convinces Magdalena to reconsider the rejection. We'll let you know when 
have her decision.
best,
Tuuli
Tuuli Lappalainen, PhD
Department of Genetics, Stanford University School of Medicine , and
Department of Genetic Medicine and Development, University of Geneva
Email:tuuli.e.lappalainen@gmail.com  /tlappala(a)stanford.edu
Tel: +1 415 351 9713
Bustamante lab
Department of Genetics
300 Pasteur Dr. Lane L301
Stanford, CA 94305-5120
USA
On /24/113 3:28 AM, Gabrielle Anne Bertier wrote:
 
 Dear all,
 Here are the details for the call:
 *TODAY -  Thursday 24th January at 16:00 CET*
 SPAIN
 	
 900800678
 GERMANY
 	
 08001013982
 NETHERLANDS
 	
 08002658044
 FRANCE
 	
 0800947739
 UNITED KINGDOM
 	
 08005285280
 UNITED STATES
 	
 8005369053
 SWEDEN
 	
 0201400578
 From Other countries
 	
 +34 917911859
 Access code:
 	
 3160100
 Thanks alot,
 Kind regards,
 Gabrielle
 */Gabrielle Bertier/*
 /Scientific Project Manager
 International and Scientific Affairs
 CRG, Center for Genomic Regulation
 Carrer Dr. Aiguader, 88/
 /08003 Barcelona, España
 /Tel: +34933160374
 Mobile: +34639960656
 email: gabrielle.bertier(a)crg.es <mailto:gabrielle.bertier@crg.es>
 web:www.geuvadis.eu; 
www.fliact.eu
 *From:*geuvadis_rna_analysis-bounces@lists.crg.es 
 [mailto:geuvadis_rna_analysis-bounces@lists.crg.es] *On Behalf Of 
 *Tuuli Lappalainen
 *Sent:* 22 January, 2013 8:37 AM
 *To:* Manolis Dermitzakis; geuvadis_rna_analysis(a)lists.crg.es
 *Subject:* [Geuvadis_rna_analysis] RNAseq paper
 Dear all,
 The Geuvadis RNAseq paper was rejected this morning. We've decided 
 with Manolis that we should make an appeal, and we have already been 
 in touch with Magdalena about this. We'll need to send her a response 
 letter in a couple of days (see the attachment with reviewer's 
 comments and a rough response draft). It ain't over til it's over.
 Since we were going to have a call soon anyway, let's have a *TC on 
 Thursday the 24th at 4pm CET*. Before that, I'd be happy to hear your 
 *comments to the response letter (deadline: immediately)*. There's a 
 couple of bigger items to discuss, and specific questions to a few of 
 you - see below. There won't be a lot of new analysis to do if we're 
 given the chance to revise.
 Questions:
 - Do we drop non-essential analyses as #2 suggests? This would mean 
 RNA editing, maybe fusions and subtle splicing. I'm not keen to, but 
 if people think it would improve the overall quality of the paper...
 - Should we restructure the supplement by topic instead of 
 methods/figures/tables? Need to ask Magdalena too.
 - Andrew & Natalja: Can we add a data slicing and download function to 
 the browser (or a separate site linked from the browser)?
 - Jean & Mar: How is the qualitative/quantitative analysis affected by 
 low-abundance transcripts? Will the results change if the threshold is 
 different?
 - Jean, Mar, Pedro, Micha (and myself): #2 raises an important 
 question (really!): most of transcript variation is explained by 
 transcript ratio differences, but we find very few QTLs for this. Why 
 do you think this is? Is all that variation really just 
 random/environmental/epigenetic?
 - Jean: #3 suspects that the 3% of transcriptome variation explained 
 by population could be just random - how do we respond to this?
 - Manny: What could we do to add novelty value to NMD analysis?
 - Gabrielle: Is it possible to make a read-only password for the wiki? 
 We could give one to the reviewers just so that they can see it.
 best regards,
 Tuuli
 -- 
 Tuuli Lappalainen, PhD
 Department of Genetics, Stanford University School of Medicine , and
 Department of Genetic Medicine and Development, University of Geneva
 Email:tuuli.e.lappalainen@gmail.com  <mailto:tuuli.e.lappalainen@gmail.com> 
/tlappala(a)stanford.edu  <mailto:tlappala@stanford.edu>
 Tel: +1 415 351 9713
 Bustamante lab
 Department of Genetics
 300 Pasteur Dr. Lane L301
 Stanford, CA 94305-5120
 USA
 _______________________________________________
 Geuvadis_rna_analysis mailing list
 Geuvadis_rna_analysis(a)lists.crg.es
 
http://davinci.crg.es/mailman/listinfo/geuvadis_rna_analysis